{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:26:56Z","timestamp":1793946416699,"version":"4.8.0"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030887","name":"Central Council for Research in Unani Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030887","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.critrevonc.2026.105495","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:58:15Z","timestamp":1784534295000},"page":"105495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Biomimetic nanoparticles for metastatic breast cancer: Advancing targeted drug delivery beyond conventional nanomedicine"],"prefix":"10.1016","volume":"226","author":[{"given":"Urushi","family":"Rehman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenzin Sonam","family":"Dongsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenzin Tsering","family":"Dongsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazeer","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan Jalees","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Kesharwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105495_bib1","article-title":"Natural products targeting the ATR-CHK1 signaling pathway in cancer therapy","volume":"155","author":"Ahmed","year":"2022","journal-title":"Biomed. & Pharmacother. = Biomedecine & Pharmacother."},{"key":"10.1016\/j.critrevonc.2026.105495_bib2","article-title":"Marine peptides in breast cancer: Therapeutic and mechanistic understanding","volume":"142","author":"Ahmed","year":"2021","journal-title":"Biomed. & Pharmacother. = Biomedecine & Pharmacother."},{"key":"10.1016\/j.critrevonc.2026.105495_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116951","article-title":"Recent advances in biomimetic cell membrane\u2013camouflaged nanoparticles for cancer therapy","volume":"177","author":"Alimohammadvand","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105495_bib4","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes. & Dis."},{"key":"10.1016\/j.critrevonc.2026.105495_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: Global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105495_bib6","first-page":"409","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nature Reviews Cancer 2015 157"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105495_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer \u2014 expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105495_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.blre.2009.04.001","article-title":"Platelet \u03b1-granules: Basic biology and clinical correlates","volume":"23","author":"Blair","year":"2009","journal-title":"Blood Rev."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105495_bib9","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.drudis.2018.02.001","article-title":"Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics","volume":"23","author":"Bose","year":"2018","journal-title":"Drug. Discov. Today"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105495_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s40271-024-00679-6","article-title":"Differences in Preferences for Drug Therapy Between Patients with Metastatic Versus Early-Stage Breast Cancer: A Systematic Literature Review","volume":"17","author":"Brandstetter","year":"2024","journal-title":"Patient"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105495_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51029-8","article-title":"Cancer cell membrane-coated mesoporous silica loaded with superparamagnetic ferroferric oxide and Paclitaxel for the combination of Chemo\/Magnetocaloric therapy on MDA-MB-231 cells","volume":"9","author":"Cai","year":"2019","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105495_bib12","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1021\/acsnano.6b03148","article-title":"Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer","volume":"10","author":"Cao","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105495_bib13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jcis.2023.02.073","article-title":"Probing the coverage of nanoparticles by biomimetic membranes through nanoplasmonics","volume":"640","author":"Cardellini","year":"2023","journal-title":"J. Colloid Interface Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105495_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10549-007-9548-1","article-title":"Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy","volume":"107","author":"Cella","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105495_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081946","article-title":"The role of macrophages in cancer development and therapy","volume":"13","author":"Cendrowicz","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105495_bib16","article-title":"Biomimetic nanoparticles: A revolutionary approach to breast cancer therapy using cell membrane coatings","volume":"107","author":"Chandra","year":"2025","journal-title":"J. Drug. Deliv. Sci. Technol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105495_bib17","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105495_bib18","doi-asserted-by":"crossref","first-page":"12849","DOI":"10.1021\/acsnano.7b08225","article-title":"Oxygen-Self-Produced Nanoplatform for Relieving Hypoxia and Breaking Resistance to Sonodynamic Treatment of Pancreatic Cancer","volume":"11","author":"Chen","year":"2017","journal-title":"ACS Nano"},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105495_bib19","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1158\/1078-0432.CCR-11-2904","article-title":"Molecular pathways: VCAM-1 as a potential therapeutic target in metastasis","volume":"18","author":"Chen","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105495_bib20","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1021\/acsnano.2c12193","article-title":"Antibodies against Poly(ethylene glycol) Activate Innate Immune Cells and Induce Hypersensitivity Reactions to PEGylated Nanomedicines","volume":"17","author":"Chen","year":"2023","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105495_bib21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1039\/D0BM01617A","article-title":"Orchestration of biomimetic membrane coating and nanotherapeutics in personalized anticancer therapy","volume":"9","author":"Chen","year":"2021","journal-title":"Biomater. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105495_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.critrevonc.2026.105495_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2867-5-30","article-title":"ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal","volume":"5","author":"Choi","year":"2005","journal-title":"Cancer Cell. Int."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105495_bib24","doi-asserted-by":"crossref","DOI":"10.4110\/in.2020.20.e9","article-title":"Clinical characteristics and treatment of immune-related adverse events of immune checkpoint inhibitors","volume":"20","author":"Choi","year":"2020","journal-title":"Immune Netw."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105495_bib25","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1021\/acsabm.2c00614","article-title":"Coating a Self-Assembly Nanoconstruct with a Neutrophil Cell Membrane Enables High Specificity for Triple Negative Breast Cancer Treatment","volume":"5","author":"Chowdhury","year":"2022","journal-title":"ACS Appl. Bio Mater."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105495_bib26","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.apsb.2022.05.027","article-title":"A neutrophil-biomimic platform for eradicating metastatic breast cancer stem-like cells by redox microenvironment modulation and hypoxia-triggered differentiation therapy","volume":"13","author":"Chu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"10265","key":"10.1016\/j.critrevonc.2026.105495_bib27","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(20)32531-9","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial","volume":"396","author":"Cortes","year":"2020","journal-title":"Lancet (Lond. Engl. )"},{"key":"10.1016\/j.critrevonc.2026.105495_bib28","first-page":"10","article-title":"Nanoparticle-based drug delivery systems for cancer therapy","volume":"1","author":"Dang","year":"2020","journal-title":"Smart Mater. Med."},{"key":"10.1016\/j.critrevonc.2026.105495_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104237","article-title":"Circulating tumor cell isolation for cancer diagnosis and prognosis","volume":"83","author":"Deng","year":"2022","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105495_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202400012","article-title":"Cell Membrane-Coated Nanoparticles: A New Frontier in Immunomodulation","volume":"4","author":"Desai","year":"2024","journal-title":"Adv. NanoBiomed Res."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105495_bib31","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.3390\/cancers15112906","article-title":"Metastatic Breast Cancer: Review of Emerging Nanotherapeutics","volume":"15","author":"Dissanayake","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105495_bib32","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.actbio.2020.06.025","article-title":"Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition","volume":"113","author":"Fan","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.critrevonc.2026.105495_bib33","article-title":"Biomimetic PLGA-based nanocomplexes for improved tumor penetration to enhance chemo-photodynamic therapy against metastasis of TNBC","volume":"16","author":"Fan","year":"2022","journal-title":"Mater. Today Adv."},{"key":"10.1016\/j.critrevonc.2026.105495_bib34","article-title":"Cell membrane biomimetic nanoplatforms: a new strategy for immune escape and precision targeted therapy","volume":"35","author":"Feng","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105495_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gendis.2018.05.001","article-title":"Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis","volume":"5","author":"Feng","year":"2018","journal-title":"Genes. & Dis."},{"key":"10.1016\/j.critrevonc.2026.105495_bib36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jconrel.2022.09.012","article-title":"Stem cell membrane-coated abiotic nanomaterials for biomedical applications","volume":"351","author":"Ferreira-Faria","year":"2022","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105495_bib37","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1016\/j.apsb.2022.11.018","article-title":"Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer","volume":"13","author":"Gao","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105495_bib38","doi-asserted-by":"crossref","first-page":"667","DOI":"10.4155\/fmc.09.55","article-title":"Designing Photosensitizers for Photodynamic Therapy: Strategies, Challenges and Promising Developments","volume":"1","author":"Garland","year":"2009","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105495_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00925-6","article-title":"Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration","volume":"8","author":"Gordon-Alonso","year":"2017","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105495_bib40","doi-asserted-by":"crossref","first-page":"13620","DOI":"10.1021\/acsnano.9b08659","article-title":"Nanomedicines Lost in Translation","volume":"13","author":"Guidolin","year":"2019","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105495_bib41","first-page":"33","article-title":"Membrane-coated nanoparticles as a biomimetic targeted delivery system for tumour therapy","volume":"5","author":"Guo","year":"2024","journal-title":"Biomater. Transl."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105495_bib42","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.nanoms.2021.12.001","article-title":"Engineering polymer nanoparticles using cell membrane coating technology and their application in cancer treatments: Opportunities and challenges","volume":"4","author":"Guo","year":"2022","journal-title":"Nano Mater. Sci."},{"key":"10.1016\/j.critrevonc.2026.105495_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101587","article-title":"Biomimetic nanotherapeutics based on oxygen supply and ultrasmall Cu-Se-Au alloy nanoparticles for boosting radio-photothermal ablation of breast cancer","volume":"46","author":"Guo","year":"2022","journal-title":"Nano Today"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105495_bib44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.58567\/ci02020007","article-title":"Cell membrane-coated nanoparticles for cancer therapy","volume":"2","author":"Hameed","year":"2023","journal-title":"Cancer Insight"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105495_bib45","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1080\/09205063.2020.1764163","article-title":"Cancer cell membrane-coated biomimetic platform for targeted therapy of breast cancer in an orthotopic mouse model","volume":"31","author":"Han","year":"2020","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105495_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121836","article-title":"Cancer cell membrane-coated nanoparticles for cancer management","volume":"11","author":"Harris","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105495_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110298","article-title":"Cell membrane-coated nanosized active targeted drug delivery systems homing to tumor cells: A review","volume":"106","author":"He","year":"2020","journal-title":"Materials Science Engineering C"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105495_bib48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10555-017-9677-x","article-title":"Normal platelet function","volume":"36","author":"Holinstat","year":"2017","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105495_bib49","first-page":"15","article-title":"Biomimetic Cell-Derived Nanoparticles: Emerging Platforms for Cancer Immunotherapy","volume":"15","author":"Hu","year":"2023","journal-title":"Pharmaceutics 2023"},{"key":"10.1016\/j.critrevonc.2026.105495_bib50","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.2147\/IJN.S321071","article-title":"Effective triple-negative breast cancer targeted treatment using iRGD-modified RBC membrane-camouflaged nanoparticles","volume":"16","author":"Huang","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105495_bib51","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00396-016-3918-3","article-title":"Magnetic hyperthermia with magnetite nanoparticles: electrostatic and polymeric stabilization","volume":"294","author":"Iglesias","year":"2016","journal-title":"Colloid Polym. Sci."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105495_bib52","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.3390\/jpm12121964","article-title":"Enhanced Permeability and Retention Effect as a Ubiquitous and Epoch-Making Phenomenon for the Selective Drug Targeting of Solid Tumors","volume":"12","author":"Islam","year":"2022","journal-title":"J. Pers. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105495_bib53","first-page":"26","article-title":"Molecular Underpinnings of Brain Metastases","volume":"26","author":"Jacome","year":"2025","journal-title":"Int. J. Mol. Sci. 2025"},{"key":"10.1016\/j.critrevonc.2026.105495_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117009","article-title":"Heterogeneity of breast cancer: The importance of interaction between different tumor cell populations","volume":"239","author":"Janu\u0161kevi\u010dien\u0117","year":"2019","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105495_bib55","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/biology9110406","article-title":"Nanoparticles Coated with Cell Membranes for Biomedical Applications","volume":"9","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2020","journal-title":"Biology"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105495_bib56","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1021\/acsnano.6b06477","article-title":"Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis","volume":"11","author":"Kang","year":"2017","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105495_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2014.12.015","article-title":"Dendrimer generational nomenclature: The need to harmonize","volume":"20","author":"Kesharwani","year":"2015","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.critrevonc.2026.105495_bib58","doi-asserted-by":"crossref","unstructured":"Khan, Z., Alhalmi, A., Tyagi, N., Khan, W.U., Sheikh, A., Abourehab, M.A.S., Kohli, K., & Kesharwani, P. (2022). Folic acid engineered sulforaphane loaded microbeads for targeting breast cancer. Https:\/\/Doi.Org\/10.1080\/09205063.2022.2144692, 1\u201320. https:\/\/doi.org\/10.1080\/09205063.2022.2144692.","DOI":"10.1080\/09205063.2022.2144692"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105495_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041057","article-title":"Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer","volume":"19","author":"Kong","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105495_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1285","article-title":"Cell membrane-coated nanoparticles for the treatment of cancer","volume":"13","author":"Krishnan","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105495_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/IJN.S579622","article-title":"Biomimetic Nanoparticles for Targeted and Efficient Cancer Therapy: Progress, Challenges and Perspectives","volume":"21","author":"Kumar","year":"2026","journal-title":"Int. J. Nanomed."},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105495_bib62","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.3390\/molecules30224487","article-title":"Vivo Behavior of Biomimetic Nanoparticles: Strategies for Clearance Avoidance, Targeting, and Functional Delivery","volume":"30","author":"Lazareva","year":"2025","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105495_bib63","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1021\/acsnano.8b04066","article-title":"Cell Membrane Coated Semiconducting Polymer Nanoparticles for Enhanced Multimodal Cancer Phototheranostics","volume":"12","author":"Li","year":"2018","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105495_bib64","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1039\/D0BM00029A","article-title":"Red blood cell membrane-coated upconversion nanoparticles for pretargeted multimodality imaging of triple-negative breast cancer","volume":"8","author":"Li","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.critrevonc.2026.105495_bib65","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.2147\/IJN.S301855","article-title":"Erythrocyte-Camouflaged Mesoporous Titanium Dioxide Nanoplatform for an Ultrasound-Mediated Sequential Therapies of Breast Cancer","volume":"16","author":"Li","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105495_bib66","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.apsb.2017.11.009","article-title":"Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment","volume":"8","author":"Li","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.critrevonc.2026.105495_bib67","article-title":"Hybrid membrane-camouflaged hollow prussian blue nanoparticles for shikonin loading and combined chemo\/photothermal therapy of metastatic TNBC","volume":"14","author":"Liang","year":"2022","journal-title":"Mater. Today Adv."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105495_bib68","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1021\/acsnanomed.5c00117","article-title":"Nanotechnology in Cancer Therapy: How Nanoparticles Are Shaping the Future of Personalized Treatment","volume":"1","author":"Lionadi","year":"2026","journal-title":"ACS Nano Med."},{"key":"10.1016\/j.critrevonc.2026.105495_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119301","article-title":"RBC membrane camouflaged prussian blue nanoparticles for gamabutolin loading and combined chemo\/photothermal therapy of breast cancer","volume":"217","author":"Liu","year":"2019","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105495_bib70","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s13346-022-01252-0","article-title":"Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system","volume":"13","author":"Liu","year":"2023","journal-title":"Drug. Deliv. Transl. Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105495_bib71","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s13346-022-01252-0","article-title":"Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system","volume":"13","author":"Liu","year":"2023","journal-title":"Drug. Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105495_bib72","article-title":"Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105495_bib73","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.7150\/thno.40805","article-title":"Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy","volume":"10","author":"Liu","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105495_bib74","doi-asserted-by":"crossref","DOI":"10.1007\/s40820-019-0330-9","article-title":"Cell Membrane Coating Technology: A Promising Strategy for Biomedical Applications","volume":"11","author":"Liu","year":"2019","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.critrevonc.2026.105495_bib75","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jconrel.2023.08.057","article-title":"Platelet-mimetic nano-sensor for combating postoperative recurrence and wound infection of triple-negative breast cancer","volume":"362","author":"Liu","year":"2023","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105495_bib76","first-page":"450","article-title":"Interaction between circulating cancer cells and platelets: Clinical implication","volume":"27","author":"Lou","year":"2015","journal-title":"Chin. J. Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105495_bib77","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0975-7406.130965","article-title":"Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues","volume":"6","author":"Madaan","year":"2014","journal-title":"J. Pharm. & Bioallied Sci."},{"issue":"0","key":"10.1016\/j.critrevonc.2026.105495_bib78","article-title":"Breast-to-brain metastasis: a focus on the pre-metastatic niche","volume":"7","author":"Malone","year":"2021","journal-title":"J Cancer Metastasis Treat 2021740."},{"key":"10.1016\/j.critrevonc.2026.105495_bib79","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/978-3-319-22536-4_22","article-title":"Sonodynamic Therapy: Concept, Mechanism and Application to Cancer Treatment","volume":"880","author":"McHale","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.critrevonc.2026.105495_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1410017","article-title":"Nanotechnology for the theranostic opportunity of breast cancer lung metastasis: recent advancements and future challenges","volume":"12","author":"Miao","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.critrevonc.2026.105495_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112803","article-title":"Biomimetic fabrication of nanotherapeutics by leukocyte membrane cloaking for targeted therapy","volume":"219","author":"Mohale","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105495_bib82","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3762\/bjnano.16.92","article-title":"Better together: biomimetic nanomedicines for high performance tumor therapy","volume":"16","author":"Mohammad","year":"2025","journal-title":"Beilstein J. Nanotechnol. 1692"},{"key":"10.1016\/j.critrevonc.2026.105495_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02774","article-title":"Neutrophil mechanosignaling promotes integrin engagement with endothelial cells and motility within inflamed vessels","volume":"9","author":"Morikis","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105495_bib84","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.molmed.2014.02.007","article-title":"MUC1: A multifaceted oncoprotein with a key role in cancer progression","volume":"20","author":"Nath","year":"2014","journal-title":"Trends Mol. Med."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105495_bib85","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1182\/blood-2004-08-2980","article-title":"Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia","volume":"105","author":"Olsson","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105495_bib86","first-page":"6910","article-title":"DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis","volume":"6","author":"Pathania","year":"2015","journal-title":"Nat. Commun. 2015 61"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105495_bib87","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.critrevonc.2026.105495_bib88","doi-asserted-by":"crossref","first-page":"10151","DOI":"10.2147\/IJN.S285952","article-title":"Platelet-Mimicking Drug Delivery Nanoparticles for Enhanced Chemo-Photothermal Therapy of Breast Cancer","volume":"15","author":"Pei","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105495_bib89","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage Diversity Enhances Tumor Progression and Metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"issue":"46","key":"10.1016\/j.critrevonc.2026.105495_bib90","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1002\/smll.201502388","article-title":"Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance","volume":"11","author":"Rao","year":"2015","journal-title":"Small"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105495_bib91","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/27\/8\/085106","article-title":"Synthetic nanoparticles camouflaged with biomimetic erythrocyte membranes for reduced reticuloendothelial system uptake","volume":"27","author":"Rao","year":"2016","journal-title":"Nanotechnology"},{"key":"10.1016\/j.critrevonc.2026.105495_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112766","article-title":"Polymeric nanoparticles-siRNA as an emerging nano-polyplexes against ovarian cancer","volume":"218","author":"Rehman","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105495_bib93","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1021\/acsabm.1c00926","article-title":"Mesoporous Doxorubicin-Loaded Polydopamine Nanoparticles Coated with a Platelet Membrane Suppress Tumor Growth in a Murine Model of Human Breast Cancer","volume":"5","author":"Ren","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.critrevonc.2026.105495_bib94","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2016.03.026","article-title":"Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy","volume":"92","author":"Ren","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.critrevonc.2026.105495_bib95","article-title":"Advancement in triple-negative breast cancer therapeutics: A comprehensive review on the potential of cell membrane-coated nanoparticles","volume":"98","author":"Rout","year":"2024","journal-title":"J. Drug. Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105495_bib96","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/ma13010065","article-title":"Dendrimers as pharmaceutical excipients: Synthesis, properties, toxicity and biomedical applications","volume":"13","author":"Santos","year":"2020","journal-title":"Materials"},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105495_bib97","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","article-title":"Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"New. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105495_bib98","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1021\/acs.molpharmaceut.3c00009","article-title":"Cancer Cell Membrane Wrapped Nanoparticles for the Delivery of a Bcl-2 Inhibitor to Triple-Negative Breast Cancer","volume":"20","author":"Scully","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.critrevonc.2026.105495_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112530","article-title":"Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer","volume":"146","author":"Sheikh","year":"2022","journal-title":"Biomed. & Pharmacother."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105495_bib100","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: The mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105495_bib101","doi-asserted-by":"crossref","unstructured":"Simon, A., & Robb, K. (2024). Breast Cancer. Cambridge Handbook of Psychology, Health and Medicine, Second Edition, 577\u2013580. https:\/\/doi.org\/10.1017\/CBO9780511543579.131.","DOI":"10.1017\/CBO9780511543579.131"},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105495_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246154","article-title":"Prostacyclin Released by Cancer-Associated Fibroblasts Promotes Immunosuppressive and Pro-Metastatic Macrophage Polarization in the Ovarian Cancer Microenvironment","volume":"14","author":"Sommerfeld","year":"2022","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105495_bib103","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1080\/09205063.2022.2056942","article-title":"Platelet-biomimetic nanoparticles for in vivo targeted photodynamic therapy of breast cancer","volume":"33","author":"Song","year":"2022","journal-title":"J. Biomater. Sci. Polym. Ed."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105495_bib104","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/adfm.201504780","article-title":"Long Circulation Red-Blood-Cell-Mimetic Nanoparticles with Peptide-Enhanced Tumor Penetration for Simultaneously Inhibiting Growth and Lung Metastasis of Breast Cancer","volume":"26","author":"Su","year":"2016","journal-title":"Adv. Funct. Mater."},{"issue":"43","key":"10.1016\/j.critrevonc.2026.105495_bib105","doi-asserted-by":"crossref","first-page":"9581","DOI":"10.1002\/adma.201602173","article-title":"Cancer-Cell-Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors","volume":"28","author":"Sun","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.critrevonc.2026.105495_bib106","article-title":"Saikosaponin D loaded macrophage membrane-biomimetic nanoparticles target angiogenic signaling for breast cancer therapy","volume":"18","author":"Sun","year":"2020","journal-title":"Appl. Mater. Today"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105495_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12122903","article-title":"Classification of White Blood Cells: A Comprehensive Study Using Transfer Learning Based on Convolutional Neural Networks","volume":"12","author":"Tamang","year":"2022","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105495_bib108","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1295\/polymj.17.117","article-title":"A New Class of Polymers: Starburst-Dendritic Macromolecules","volume":"17","author":"Tomalia","year":"1985","journal-title":"Polym. J."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105495_bib109","first-page":"143","article-title":"The promise of sonodynamic therapy","volume":"33","author":"Trendowski","year":"2013","journal-title":"Cancer Metastasis Reviews 2013 331"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105495_bib110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: Molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105495_bib111","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-981-13-0445-3_3","article-title":"Cell membrane coated nanoparticles: an emerging biomimetic nanoplatform for targeted bioimaging and therapy","volume":"1064","author":"Vijayan","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.critrevonc.2026.105495_bib112","article-title":"Development of a biomimetic nanoparticle platform for apigenin therapy in triple-negative breast cancer","volume":"15","author":"Wang","year":"2025","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105495_bib113","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1007\/s12274-024-6412-0","article-title":"Targeted nanostrategies eliminate pre-metastatic niche of cancer","volume":"17","author":"Wang","year":"2024","journal-title":"Nano Res."},{"key":"10.1016\/j.critrevonc.2026.105495_bib114","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1016\/j.csbj.2023.04.024","article-title":"Sequential targeting biomimetic nano platform for enhanced mild photothermal therapy and chemotherapy of tumor","volume":"21","author":"Wang","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"14","key":"10.1016\/j.critrevonc.2026.105495_bib115","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1021\/jacs.9b10228","article-title":"Ultrafine Titanium Monoxide (TiO1+ x) Nanorods for Enhanced Sonodynamic Therapy","volume":"142","author":"Wang","year":"2020","journal-title":"J. Am. Chem. Soc."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105495_bib116","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/rheumatology\/keq045","article-title":"Neutrophil function in inflammation and inflammatory diseases","volume":"49","author":"Wright","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.critrevonc.2026.105495_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.648407","article-title":"Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance","volume":"12","author":"Xiao","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105495_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201802244","article-title":"Emerging Strategies of Nanomaterial-Mediated Tumor Radiosensitization","volume":"31","author":"Xie","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.critrevonc.2026.105495_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2022.111219","article-title":"Biomimetic hybrid-cell membrane nanoparticles loaded with panaxytriol for breast cancer combinational therapy","volume":"223","author":"Xie","year":"2022","journal-title":"Mater. Des."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105495_bib120","first-page":"1","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal. Transduct. Target. Ther. 2025 101"},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105495_bib121","doi-asserted-by":"crossref","first-page":"9610","DOI":"10.1021\/acsami.6b00853","article-title":"Macrophage Cell Membrane Camouflaged Au Nanoshells for in Vivo Prolonged Circulation Life and Enhanced Cancer Photothermal Therapy","volume":"8","author":"Xuan","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.critrevonc.2026.105495_bib122","article-title":"The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105495_bib123","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1021\/acsnano.7b09041","article-title":"Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination","volume":"12","author":"Yang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105495_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.03.024","article-title":"Bioinspired nanoplatelets for chemo-photothermal therapy of breast cancer metastasis inhibition","volume":"206","author":"Ye","year":"2019","journal-title":"Biomaterials"},{"issue":"37","key":"10.1016\/j.critrevonc.2026.105495_bib125","doi-asserted-by":"crossref","DOI":"10.1002\/advs.71800","article-title":"Targeting Hyperglycemic Bone Pre-Metastatic Niche for Breast Cancer Bone Metastasis Therapy","volume":"12","author":"Ye","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.critrevonc.2026.105495_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114083","article-title":"Clinical translation of nanomedicines: Challenges, opportunities, and keys","volume":"181","author":"Younis","year":"2022","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.critrevonc.2026.105495_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108108","article-title":"Challenges and Opportunities in Metastatic Breast Cancer Treatments: Nano-Drug Combinations Delivered Preferentially to Metastatic Cells May Enhance Therapeutic Response","volume":"236","author":"Yu","year":"2022","journal-title":"Pharmacol. & Ther."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105495_bib128","doi-asserted-by":"crossref","first-page":"237","DOI":"10.21147\/j.issn.1000-9604.2017.03.10","article-title":"Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance","volume":"29","author":"Yu","year":"2017","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105495_bib129","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.2147\/IJN.S502144","article-title":"Advancements in Cell Membrane-Derived Biomimetic Nanotherapeutics for Breast Cancer","volume":"20","author":"Zeng","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.critrevonc.2026.105495_bib130","article-title":"Cell membrane-coated nanomaterials for cancer therapy","volume":"20","author":"Zeng","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.critrevonc.2026.105495_bib131","article-title":"Combination of photothermal, prodrug and tumor cell camouflage technologies for triple-negative breast cancer treatment","volume":"13","author":"Zhang","year":"2022","journal-title":"Mater. Today Adv."},{"key":"10.1016\/j.critrevonc.2026.105495_bib132","article-title":"Research progress of cell membrane biomimetic nanoparticles for circulating tumor cells","volume":"14","author":"Zhang","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105495_bib133","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2017.01.016","article-title":"Erythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection","volume":"263","author":"Zhang","year":"2017","journal-title":"J. Control. Release"},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105495_bib134","article-title":"Activated platelets-targeting micelles with controlled drug release for effective treatment of primary and metastatic triple negative breast cancer","volume":"29","author":"Zhang","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.critrevonc.2026.105495_bib135","doi-asserted-by":"crossref","first-page":"8249","DOI":"10.2147\/IJN.S531558","article-title":"Application of biomimetic cell membrane-coated nanocarriers in cardiovascular diseases","volume":"20","author":"Zhao","year":"2025","journal-title":"Int. J. Nanomed."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105495_bib136","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1021\/acs.biomac.1c00440","article-title":"Hybrid membrane-coated biomimetic nanoparticles (hm@bnps): a multifunctional nanomaterial for biomedical applications","volume":"22","author":"Zhao","year":"2021","journal-title":"Biomacromolecules"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105495_bib137","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1021\/acs.molpharmaceut.4c00950","article-title":"Macrophage Membrane-Coated Nanomedicine Enhances Cancer Immunotherapy by Activating Macrophages and T Cells","volume":"22","author":"Zhao","year":"2025","journal-title":"Mol. Pharm."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:41:28Z","timestamp":1793943688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826003823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":137,"alternative-id":["S1040842826003823"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105495","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomimetic nanoparticles for metastatic breast cancer: Advancing targeted drug delivery beyond conventional nanomedicine","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105495"}}